MEBROFENINA INJ. 20 MG - AUE 1590/2025
About This Opportunity
TranslatedThis tender pertains to the procurement of Mebrofenina Injection at a concentration of 20 mg, identified by the reference AUE 1590/2025. The primary objective of this tender is to secure a reliable supply of this pharmaceutical product, which is essential for medical treatments. Key requirements for bidders may include compliance with regulatory standards for pharmaceutical products, proof of manufacturing capabilities, and adherence to quality assurance protocols. The tender is likely to be issued by a governmental health agency or a public health institution, focusing on the healthcare sector. Interested parties should prepare to demonstrate their ability to meet the specified dosage and formulation requirements, as well as provide evidence of previous experience in similar contracts. The location of the tender process is expected to be within the jurisdiction of the issuing authority, and bidders may need to comply with local regulations regarding the distribution of medical supplies. Timely delivery and competitive pricing will be critical factors in the evaluation of proposals. This tender represents an opportunity for pharmaceutical companies to contribute to public health initiatives by providing essential medications.
This is a supplies contract in the health and medical services, information and communication technology and transport and logistics sectors, with a focus on Pharmaceuticals and Logistics. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,800.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "MEBROFENINA INJ. 20 MG - AUE 1590/2025" pertains to the procurement of a pharmaceutical product, specifically Mebrofenin Injection at a concentration of 20 mg. This tender is issued in Portugal, a country known for its systematic approach to public procurement, particularly in the healthcare sector. The contracting authority for this tender is not explicitly stated; however, it is likely to involve public health institutions or government agencies responsible for healthcare procurement.
This procurement seeks qualified suppliers capable of delivering Mebrofenin Injection that meets the regulatory standards and quality specifications outlined by Portuguese health authorities. Typical requirements for such tenders include compliance with good manufacturing practices (GMP), appropriate documentation demonstrating product efficacy and safety, and adherence to local and European pharmaceutical regulations. Suppliers will be expected to provide detailed technical specifications, pricing information, and delivery timelines.
Additionally, bidders may need to demonstrate their experience in supplying similar pharmaceutical products, capacity for large-scale production, and ability to respond to the logistics demands of healthcare facilities. The procurement process is geared towards ensuring that healthcare providers have access to essential medications that contribute to patient care and treatment outcomes. Interested parties are encouraged to review the tender documents thoroughly and prepare their submissions in accordance with the guidelines provided on the BASE portal, which centralizes public contract information in Portugal.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 10, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Almada-Seixal, EPE
Unidade Local de Saúde de Almada-Seixal, EPE has issued 1,414 procurement notices on BidsFactory, including 3 currently open and 1,382 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to DILOFAR DISTRIBUICAO TRANSPORTES E LOGISTICA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Almada-Seixal, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €1,800. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.